Huan Lu1, Peng-Cheng Jiang2, Xiao-Dan Zhang3, Wen-Jing Hou1, Zhen-Hong Wei1, Jia-Qi Lu4, Hao Zhang4, Guang-Xu Xu1, Yuan-Ping Chen1, Yuan Ren5, Li Wang6, Rong Zhang1, Ying Han1. 1. Department of Obstetrics and Gynecology, Fengxian Hospital, Southern Medical University Shanghai 201499, P. R. China. 2. Department of Obstetrics and Gynecology, Changzhou NO. 2 People's Hospital Changzhou 213003, Jiangsu, P. R. China. 3. Medical College of Nanchang University Nanchang 330000, Jiangxi, P. R. China. 4. Obstetrics and Gynecology Hospital, Fudan University Shanghai 200011, P. R. China. 5. Obstetrics and Gynecology Hospital, Fudan UniversityShanghai 200011, P. R. China; Changzhou Maternal and Child Health Care HospitalChangzhou 213003, Jiangsu, P. R. China. 6. Changzhou Maternal and Child Health Care Hospital Changzhou 213003, Jiangsu, P. R. China.
Abstract
UNLABELLED: High risk human papillomavirus (HPV) infection is the major cause of cervical cancer. Bacterial vaginosis (BV) is considered as the most prevalent vaginal imbalance affecting women of reproductive age. However, the relationship between HPV and BV infection is unclear. This study aimed to assess the prevalence of human papillomavirus (HPV) infection combined with bacterial vaginosis (BV) infection in Shanghai suburbs and evaluate associations between bacterial vaginosis with HPV infection, cervical intraepithelial neoplasia (CIN) and cervical cancer. METHODS: From October 1, 2009 to October 31, 2013, a total number of 3502 women who visited Fengxian Hospital, Southern Medical University were enrolled in this study. All participants gave informed consent and agreed to HPV, BV, chlamydia, mycoplasma and thinprepcytologic test (TCT). In addition, all women took histopathologic examination under colposcopy. Statistical analyses were done using SPSS 17.0 for windows (IBM). In present study the overall BV-positive rate was 9.25%. The top three high risk HPV types were listed as follows (in descending order): HPV16, 52, 58. Moreover, our data showed BV infection tended to occur in the HPV positive women, HPV infection also tended to occur in the BV positive women. Most of the women who present HPV with BV infection were younger than 30 years old. We also found that CIN and cervical cancer occurred mainly in HPV/BV positive and HPV with BV positive group. BV infection and HPV infection may haveconsistency or synergies. HPV with BV infection may increase the incidence of CIN and cervical cancer.
UNLABELLED: High risk human papillomavirus (HPV) infection is the major cause of cervical cancer. Bacterial vaginosis (BV) is considered as the most prevalent vaginal imbalance affecting women of reproductive age. However, the relationship between HPV and BV infection is unclear. This study aimed to assess the prevalence of human papillomavirus (HPV) infection combined with bacterial vaginosis (BV) infection in Shanghai suburbs and evaluate associations between bacterial vaginosis with HPV infection, cervical intraepithelial neoplasia (CIN) and cervical cancer. METHODS: From October 1, 2009 to October 31, 2013, a total number of 3502 women who visited Fengxian Hospital, Southern Medical University were enrolled in this study. All participants gave informed consent and agreed to HPV, BV, chlamydia, mycoplasma and thinprepcytologic test (TCT). In addition, all women took histopathologic examination under colposcopy. Statistical analyses were done using SPSS 17.0 for windows (IBM). In present study the overall BV-positive rate was 9.25%. The top three high risk HPV types were listed as follows (in descending order): HPV16, 52, 58. Moreover, our data showed BV infection tended to occur in the HPV positive women, HPV infection also tended to occur in the BV positive women. Most of the women who present HPV with BV infection were younger than 30 years old. We also found that CIN and cervical cancer occurred mainly in HPV/BV positive and HPV with BV positive group. BV infection and HPV infection may haveconsistency or synergies. HPV with BV infection may increase the incidence of CIN and cervical cancer.
Authors: Katherine A Fethers; Christopher K Fairley; Jane S Hocking; Lyle C Gurrin; Catriona S Bradshaw Journal: Clin Infect Dis Date: 2008-12-01 Impact factor: 9.079
Authors: K L Wallin; F Wiklund; T Angström; F Bergman; U Stendahl; G Wadell; G Hallmans; J Dillner Journal: N Engl J Med Date: 1999-11-25 Impact factor: 91.245
Authors: Sheri A Denslow; Daniel J Westreich; Cynthia Firnhaber; Pam Michelow; Sophie Williams; Jennifer S Smith Journal: Int J Gynaecol Obstet Date: 2011-06-16 Impact factor: 3.561
Authors: Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch Journal: Lancet Oncol Date: 2010-10-15 Impact factor: 41.316
Authors: Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet Journal: Clin Infect Dis Date: 2003-02-07 Impact factor: 9.079
Authors: Alizee Lebeau; Diane Bruyere; Patrick Roncarati; Paul Peixoto; Eric Hervouet; Gael Cobraiville; Bernard Taminiau; Murielle Masson; Carmen Gallego; Gabriel Mazzucchelli; Nicolas Smargiasso; Maximilien Fleron; Dominique Baiwir; Elodie Hendrick; Charlotte Pilard; Thomas Lerho; Celia Reynders; Marie Ancion; Roland Greimers; Jean-Claude Twizere; Georges Daube; Geraldine Schlecht-Louf; Françoise Bachelerie; Jean-Damien Combes; Pierrette Melin; Marianne Fillet; Philippe Delvenne; Pascale Hubert; Michael Herfs Journal: Nat Commun Date: 2022-02-28 Impact factor: 17.694